[Evaluation of oral drugs for intermittent claudication of the legs in phase III clinical trials. Options selected for the ACT study].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic / Q000379:methods*; D005260:Female; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D012107:Research Design; D013876:Thiophenes / Q000008:administration & dosage / Q000627:therapeutic use*; D013988:Ticlopidine
D000925:Anticoagulants; D013876:Thiophenes; D013988:Ticlopidine
Evaluation des médicaments par voie orale de la claudication intermittente des membres inférieurs à la phase III des essais cliniques. Choix retenus dans l'étude ACT.